Recurrent COVID‐19 pneumonia in the course of chemotherapy: Consequence of a weakened immune system?

Autor: Luciani, Michelangelo, Bentivegna, Enrico, Spuntarelli, Valerio, Lamberti, Piera Amoriello, Cacioli, Giulio, Del Porto, Flavia, Sesti, Giorgio, Martelletti, Paolo, De Biase, Luciano
Předmět:
Zdroj: Journal of Medical Virology; Apr2021, Vol. 93 Issue 4, p1882-1884, 3p
Abstrakt: 2020; 2: 710 - 713. https://doi.org/10.1007/s42399-020-00335-8 3 Bentivegna E, Sentimentale A, Luciani M, Speranza ML, Guerritore L, Martelletti P. New IgM seroconversion and positive RT-PCR test after exposure to the virus in recovered COVID-19 patient. Incidence and determinants of high-sensitivity troponin and natriuretic peptides elevation at admission in hospitalized COVID-19 pneumonia patients. During the currently ongoing coronavirus disease 2019 (COVID-19) pandemic, one of the objectives that the scientific community is pursuing is to understand whether acquired immunity and antibodies positivity against acute coronavirus 2 (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) protect against reinfection.1,2 Some reports have described re-positivization of nose-pharyngeal swab polymerase chain reaction real time test (NPST), and have discussed possible interpretations for clinical healing or relapse of COVID-19.3 Genomic analysis have proved that there is chance of reinfection with different strains rather than the same strain.4 Herein, we report a case of recurrent COVID-19 pneumonia in a vulnerable patient. [Extracted from the article]
Databáze: Complementary Index